Photocure ASA Logo

Photocure ASA

Develops and commercializes photodynamic technology for bladder cancer.

PHO | OL

Overview

Corporate Details

ISIN(s):
NO0010000045
LEI:
5967007LIEEXZXG8OW35
Country:
Norway
Address:
HOFFSVEIEN 4, 0275 OSLO

Description

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-04-11 06:09
Major shareholder disclosure - Photocure ASA
English 294 bytes
2023-04-04 11:55
Major shareholder disclosure in Photocure ASA
English 161.4 KB
2023-04-04 11:55
Major shareholder disclosure in Photocure ASA
English 296 bytes
2023-03-30 08:48
Photocure ASA - Share option grant
English 107.4 KB
2023-03-30 08:48
Photocure ASA - Share option grant
English 1.6 KB
2023-03-21 20:57
Photocure provides update on Karl Storz's commitment to maximize the commercial…
English 171.8 KB
2023-03-21 20:57
Photocure provides update on Karl Storz's commitment to maximize the commercial…
English 7.8 KB
2023-03-14 07:00
Photocure: New data presented at EAU 2023 highlight the effects of blue light c…
English 180.3 KB
2023-03-14 07:00
Photocure: New data presented at EAU 2023 highlight the effects of blue light c…
English 8.4 KB
2023-02-24 14:57
NOTIFICATION OF MAJOR HOLDINGS
English 127.2 KB
2023-02-24 14:57
NOTIFICATION OF MAJOR HOLDINGS
English 266 bytes
2023-02-24 07:17
Photocure ASA – Major shareholding disclosure
English 851 bytes
2023-02-23 07:00
Photocure ASA: Results for the fourth quarter of 2022
English 529.9 KB
2023-02-23 07:00
Photocure ASA: Results for the fourth quarter of 2022
English 1.3 MB
2023-02-23 07:00
Photocure ASA: Results for the fourth quarter of 2022
English 218.8 KB

Automate Your Workflow. Get a real-time feed of all Photocure ASA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Photocure ASA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Photocure ASA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alzinova AB Logo
Clinical-stage biopharma developing immunotherapies for Alzheimer's disease.
Sweden
ALZ
AMARIN CORP PLC\UK Logo
Develops and commercializes therapeutics to improve cardiovascular health.
United States of America
AMRN
AMGEN INC Logo
A biotechnology company developing human therapeutics for serious illnesses.
United States of America
AMGN
Industrial biotechnology company specializing in specialty enzymes and proteins.
South Korea
092040
AMICUS THERAPEUTICS, INC. Logo
Biotechnology company developing therapies for rare genetic and devastating diseases.
United States of America
FOLD
AMINOLOGICS CO.,LTD. Logo
Specialty manufacturer of high-purity chiral amino acids and their derivatives.
South Korea
074430
Amneal Pharmaceuticals, Inc. Logo
Develops, manufactures, and distributes generic and specialty pharmaceuticals.
United States of America
AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops, manufactures, and markets technically challenging medications.
United States of America
AMPH
Amylyx Pharmaceuticals, Inc. Logo
Develops therapies for neurodegenerative diseases and other unmet medical needs.
United States of America
AMLX
AN2 Therapeutics, Inc. Logo
Biopharmaceutical firm developing boron-based drugs for infectious diseases.
United States of America
ANTX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.